News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Brainsway (BRSYF.PK) Reports Positive Preliminary Results of Study Using Deep TMS to Treat OCD



7/3/2012 8:30:38 AM

JERUSALEM, July 3, 2012 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results with respect to a clinical trial being conducted at the Sheba Medical Center at Tel Hashome to assess the efficacy of the Company's Deep TMS device in treating obsessive-compulsive disorder ("OCD") using a specialized coil developed for this purpose.

Read at GlobeNewswire


comments powered by Disqus
Brainsway
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES